Akèy › Limfom Difize Gwo Selil B › Florid › Orlando
Etid klinik pou Limfom Difize Gwo Selil B nan Orlando, FL
5 etid pou Limfom Difize Gwo Selil B ap chèche patisipan nan sit nan ak bò kote Orlando (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003)
Ap rekriteFaz 2/3
- Clermont Oncology Center ( Site 0174), Clermont · 24 mi lwen
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
Ap rekriteFaz 3
- Orlando Health Cancer Institute ( Site 0169), Ocoee · 10 mi lwen
- Clermont Oncology Center ( Site 0182), Clermont · 24 mi lwen
Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL
Ap rekriteFaz 2
- Orlando Health Cancer Institute, Orlando
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
Ap rekriteFaz 2
- Advent Health Cancer Institute, Orlando
- Orlando Health Cancer Institute, Orlando
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
Ap rekriteFaz 3
- AdventHealth, Orlando
Etid Limfom Difize Gwo Selil B nan lòt vil
- New York City, NY21 etid
- Baldwin Park, CA19 etid
- Chicago, IL18 etid
- Los Angeles, CA17 etid
- Houston, TX17 etid
- Boston, MA16 etid
- Milwaukee, WI16 etid
- Portland, OR15 etid
- Philadelphia, PA15 etid
- Durham, NC14 etid
- Nashville, TN14 etid
- Dallas, TX13 etid
Lòt etid nan Orlando
- Kansè Poumon ki pa ti selil44 etid
- Kansè Metastatik29 etid
- Obèsite29 etid
- Kansè (tout kalite)25 etid
- Maladi Alzheimer25 etid
- Sipwa25 etid
- Dyabèt Tip 224 etid
- Kansè nan tete23 etid
- Kolit Ulseratif23 etid
- Kansè ovè22 etid
- Kansè poumon21 etid
- Kansè kolorektal19 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.